Icahn School of Medicine at Mount Sinai
1,001
180
219
593
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
12.4%
124 terminated/withdrawn out of 1001 trials
82.7%
-3.8% vs industry average
13%
127 trials in Phase 3/4
45%
265 of 593 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (1001)
The Ambient Light Multiple Myeloma Study
Role: lead
Kaneka iED Coil System for the Treatment of Wide Necked Ruptured and Unruptured Intracranial Aneurysms
Role: lead
Family-Based Interoceptive Exposure for Avoidant Restrictive Food Intake Disorder
Role: lead
Evaluation of Muscle Oxygen With MRI
Role: lead
Deucravacitinib in the Treatment of Cicatricial Alopecias
Role: lead
Transcranial Magnetic Stimulation in Misophonia
Role: lead
Vestibular Innovation in Pain 2
Role: lead
Resilient Together for Dementia (RT-D)
Role: lead
Study on Moebius Syndrome and Congenital Facial Weakness Disorders
Role: collaborator
Patient Positioning for Treatment of Proximal Ureteral Stones
Role: lead
Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and Lichen Planopilaris
Role: lead
Multimodal Differences in Effort-based Decision-Making in Depression
Role: collaborator
Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients
Role: collaborator
Intrarenal Pressure in Suctioning vs. Non-suctioning Sheaths
Role: lead
A Genomic Approach for Clopidogrel in Caribbean Hispanics
Role: collaborator
Methodology Issues in a Tailored Light Treatment for Persons With Dementia - Aim 2
Role: lead
Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease Patients
Role: lead
CTSN Embolic Protection Trial
Role: lead
Circumferential Vertebral Reconstruction of Osteoporotic Compression Fractures Using a Novel Bipedicular Peek Implant
Role: lead
FOXP1 Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing FOXP1-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.
Role: lead